Table 4 Comparison in relative percentage of DDDs of oral antibacterials before and after intervention
From: An outpatient antibacterial stewardship intervention during the journey to JCI accreditation
Oral antibacterials | Relative percentage of DDDs | |
|---|---|---|
First phase (March, 2012) | Second phase (March, 2013) | |
Cefuroxime axetil tablets# | 10.6% | 13.2% |
Levofloxacin tablets# | 9.6% | 12.6% |
Moxifloxacin tablets# | 8.6% | 9.1% |
Amoxicillin# | 8.1% | 11.4% |
Cefdinir capsules | 7.0% | 7.2% |
Clarithromycin tablets# | 5.7% | 7.4% |
Cefradine capsules# | 3.1% | 1.8% |
Ornidazole tablets# | 2.3% | 2.8% |
Cefaclor SR tablets & Cefaclor capsules# | 1.8% | 9.3% |
Cefprozi tablets# | 1.72% | 1.2% |
Clindamycin palmitate tablets# | 0.48% | 1.2% |